How to evaluate plaque vulnerability in animal models of atherosclerosis?

被引:69
|
作者
Rekhter, MD [1 ]
机构
[1] Pfizer Global Res & Dev, Ann Arbor Labs, Dept Cardiovasc Pharmacol, Ann Arbor, MI 48105 USA
关键词
atherosclerosis; thrombosis/embolism;
D O I
10.1016/S0008-6363(01)00537-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention of heart attack and stroke depends on detection of vulnerable plaques and development of plaque-stabilizing therapies. In turn, progress in diagnostics and treatment is contingent on our understanding of molecular mechanisms of plaque vulnerability. Animal models are essential for testing mechanistic hypotheses in a controlled manner. Currently, there is no single, golden standard animal model of a vulnerable plaque. However, the whole range of experimental approaches is readily available. It includes traditional models of atherosclerosis combined with new 'vulnerability endpoints', as well as several models featuring spontaneous or induced plaque rupture/thrombosis. This review summarizes current literature on the animal models of vulnerable atherosclerotic plaques. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [1] Animal models to study plaque vulnerability
    Schapira, K.
    Heeneman, S.
    Daemen, M. J. A. P.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (10) : 1013 - 1020
  • [2] Breaking the plaque - Evidence for plaque rupture in animal models of atherosclerosis
    Bennett, MR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 713 - 714
  • [3] Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis
    Lv, Yun-Bo
    Jing, Jing
    Li, Jun-Ming
    Zhong, Jin-Peng
    Fang, Ling
    Yang, Bo
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (12) : 1031 - 1037
  • [4] Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression
    Millon, Antoine
    Canet-Soulas, Emmanuelle
    Boussel, Loic
    Fayad, Zahi
    Douek, Philippe
    VASCULAR, 2014, 22 (03) : 221 - 237
  • [5] MITOCHONDRIAL DYSFUNCTION IN CAROTID PLAQUE ATHEROSCLEROSIS A PREDICTOR OF PLAQUE VULNERABILITY
    Mercer, J. R.
    ATHEROSCLEROSIS, 2015, 241 (01) : E79 - E79
  • [6] Role of sirtuins in attenuating plaque vulnerability in atherosclerosis
    Velpuri, Prathosh
    Rai, Vikrant
    Agrawal, Devendra K.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (01) : 51 - 62
  • [7] MONOCYTE AND MACROPHAGE DYNAMICS IN ATHEROSCLEROSIS AND PLAQUE VULNERABILITY
    De Winther, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 28 - 29
  • [8] Role of sirtuins in attenuating plaque vulnerability in atherosclerosis
    Prathosh Velpuri
    Vikrant Rai
    Devendra K. Agrawal
    Molecular and Cellular Biochemistry, 2024, 479 : 51 - 62
  • [9] How valid are animal models to evaluate treatments for pulmonary hypertension?
    Maria E. Campian
    Maxim Hardziyenka
    Martin C. Michel
    Hanno L. Tan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373 : 391 - 400
  • [10] How valid are animal models to evaluate treatments for pulmonary hypertension?
    Campian, Maria E.
    Hardziyenka, Maxim
    Michel, Martin C.
    Tan, Hanno L.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (06) : 391 - 400